Singapore Apr 20, 2022
S’pore authorizes use of molnupiravir for Covid-19 patients
The Health Sciences Authority (HSA) has granted authorization for the use of molnupiravir as an oral treatment for mild to moderate Covid-19. The drug is recommended to be administered within five days of the onset of symptoms for a period of five days. It can be used by anyone above 18 with Covid-19 symptoms and […]
By Jasmime Kaur